Image

Development of utrophin modulators for the treatment of Duchenne Muscular Dystrophy

Image

Developing small molecules for the treatment of age-related diseases

Image

New agents for tumour detection and therapy

Image

Development of anti-inflammatory agents

Welcome to the Russell Group webpages. The Russell Group is based in the Department of Chemistry and the Department of Pharmacology at the University of Oxford. Explore our website to learn more about our group, collaborative research programmes and publications.


Latest news
Stacks Image 283
Prize for Daniel Lucy
Congratulations to Daniel Lucy (pictured third from the top left) who won a prize for his talk at the Astra Zeneca sponsored Final Year Symposium held at the Department of Chemistry on 22nd/23rd May 2019.
Stacks Image 286
Running for success in the Oxford Town and Gown 10km race
Well done to (pictured from left to right) Jacob Locke-Gotel, Dan Lucy, David Zimmer, Sebastien Galan, Libby Brown, and Isabel Wilkinson (not in photo) for running the Oxford Town and Gown 10km race on Sunday 12th May. The team was running to raise awareness of the AJR group's research towards the development of small molecule utropin modulators for the treatment of Duchenne Muscular Dystrophy (DMD).
Publication highlights
Image

Nature Comms paper highlights a new strategy for targeting protein-protein interactions (PPIs) for the development of new small molecule therapeutics.

Results from a collaboration between the Rabbitts Group (MRC Weatherall Institute of Molecular Medicine, WIMM) and the Russell group (Depts Chemistry and Pharmacology) has recently been published in Nature Communications.

Read more…